Please try another search
Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that is used in the production of blood cells in the bone marrow. The company was incorporated in 2012 and is based in Redwood City, California. As of January 11, 2023, Imago BioSciences, Inc. operates as a subsidiary of Merck Sharp & Dohme LLC.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review